In a study by Wei et al., bioinformatics analysis was used to demonstrate that NDC80 and MAD2L1 were potential biomarkers for the diagnosis of non-small-cell lung cancer [37]. This evidence concerns the gene MAD2L1 and non-small cell lung carcinoma.